Investor and operating executive focused on growth-stage tech and consumer businesses. Amber Baker combines strategic investing with hands-on operational experience across scaling product, go-to-market and finance functions; has led corporate development and portfolio operational roles and frequently advises CEOs on growth execution and capital formation. Prior experience spans venture-backed startups and corporate strategy. Known for sourcing cross-border deals, structuring minority growth investments and driving revenue-led scale for late-seed to Series C opportunities.
Investor and operating executive focused on growth-stage tech and consumer businesses. Amber Baker combines strategic investing with hands-on operational experience across scaling product, go-to-market and finance functions; has led corporate development and portfolio operational roles and frequently advises CEOs on growth execution and capital formation. Prior experience spans venture-backed startups and corporate strategy. Known for sourcing cross-border deals, structuring minority growth investments and driving revenue-led scale for late-seed to Series C opportunities.
Focuses on growth-stage tech and consumer companies, deploying minority growth capital alongside hands-on operational support to scale product, go-to-market and finance functions. Prefers late-seed to Series C opportunities with clear revenue traction and unit-economics improvement potential, using a revenue-led underwriting lens and founder-aligned deal structures. Emphasizes cross-border sourcing, pragmatic cap‑table construction, 3–7 year value realization horizons, active portfolio involvement to drive customer acquisition, unit margin expansion and disciplined follow-on allocation.
Focuses on growth-stage tech and consumer companies, deploying minority growth capital alongside hands-on operational support to scale product, go-to-market and finance functions. Prefers late-seed to Series C opportunities with clear revenue traction and unit-economics improvement potential, using a revenue-led underwriting lens and founder-aligned deal structures. Emphasizes cross-border sourcing, pragmatic cap‑table construction, 3–7 year value realization horizons, active portfolio involvement to drive customer acquisition, unit margin expansion and disciplined follow-on allocation.
| Trades 879 | Longs Won 652/879 74% | Profit Factor 3.53 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $422,690.96 |
| Average Win $65,272.48 | Best Trade (Aug 17) $8.33M | Sharpe Ratio -9.24 |
| Average Loss -$53,090.57 | Worst Trade (Aug 07) -$9.36M | Z-Score 9.41 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2m 1w 2d | Expectancy $34,705.46 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.52% |
| Consecutive Losing Trades | 2,427 | 2,184 | 1,942 | 1,699 | 1,456 | 1,214 | 971 | 728 | 485 | 243 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 11,113 | $2.17M | $3.43M | - | $1.26M | 58.11% | -7.354% |
ABBV AbbVie Inc. | 2,279 | $366,209.04 | $571,892.26 | - | $205,683.22 | 56.17% | -2.513% |
ACWI iShares MSCI ACWI ETF | 1,645 | $232,751 | $257,327.33 | - | $24,576.33 | 10.56% | +0.495% |
ADT ADT Inc. | 25,382 | $210,711.14 | $193,918.48 | - | -$16,792.66 | -7.97% | +1.731% |
AIZ Assurant Inc. | 1,096 | $232,473.73 | $305,992.24 | - | $73,518.51 | 31.62% | -1.158% |
ALL Allstate Corporation | 1,448 | $299,505.19 | $382,387.82 | - | $82,882.63 | 27.67% | -0.49% |
ALSN Allison Transmission Holdings Inc. | 2,055 | $140,461.14 | $235,379.7 | - | $94,918.56 | 67.58% | -0.78% |
AMZN Amazon.com Inc | 25,367 | $4.01M | $6.89M | - | $2.88M | 71.81% | +15.321% |
AVGO Broadcom Inc. | 3,251 | $813,360.59 | $1.27M | - | $452,188.69 | 55.6% | +0.371% |
AXP American Express Company | 890 | $243,867.56 | $299,262.5 | - | $55,394.94 | 22.72% | -0.376% |
BAC Bank of America Corporation | 4,911 | $270,105 | $304,236.45 | - | $34,131.45 | 12.64% | +0.356% |
BMY Bristol-Myers Squibb Company | 4,645 | $250,551 | $303,364.95 | - | $52,813.95 | 21.08% | +0.694% |
BNDX Vanguard Total International Bond ETF | 4,504 | $217,633 | $215,156.08 | - | -$2,476.92 | -1.14% | -0.23% |
BRK-B Berkshire Hathaway Inc. | 952 | $413,744.9 | $486,986.08 | - | $73,241.18 | 17.7% | +0.365% |
BWA BorgWarner Inc. | 5,327 | $240,035 | $339,542.98 | - | $99,507.98 | 41.46% | -1.04% |
BYD Boyd Gaming Corporation | 2,632 | $224,352 | $223,877.91 | - | -$474.09 | -0.21% | -2.286% |
CAH Cardinal Health Inc. | 1,778 | $184,555.95 | $408,993.34 | - | $224,437.39 | 121.61% | +1.304% |
CALM Cal-Maine Foods Inc. | 3,115 | $319,047.97 | $273,434.7 | - | -$45,613.27 | -14.3% | +0.804% |
CCK Crown Holdings Inc. | 2,350 | $241,980 | $276,947.5 | - | $34,967.5 | 14.45% | -0.439% |
CINF Cincinnati Financial Corporation | 1,251 | $204,313 | $222,277.67 | - | $17,964.67 | 8.79% | +1.688% |